Posted September 17, 2019
Chakrabarty A, Bhola NE, R Sutton C, Ghosh R, Kuba MG, Davé B, Chang JC, Arteaga CL. Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-survivin axis and are sensitive to PI3K inhibitors. Cancer Res. 2013 Feb 1;73(3):1190-200.